Three Dividend Kings—AbbVie, Walmart, Becton Dickinson—Are Buys on the Dip

Industry
โดย Motley Fool·Read original
Summary · why it matters

Three Dividend King stocks—AbbVie, Walmart, and Becton, Dickinson—are worth buying on recent price dips, according to a Motley Fool analysis. AbbVie shares are down 5% year to date amid healthcare sector weakness, but the drugmaker exceeded first-quarter expectations and its Skyrizi and Rinvoq franchises remain strong long-term growth drivers. Walmart’s stock dropped after its latest earnings on a cautious outlook, yet its Everyday Low Price model, expanding e-commerce and digital advertising, and 53-year streak of dividend increases support its long-term appeal. Becton, Dickinson has lagged the market amid slow growth, but over 90% of its revenue comes from recurring consumables, it is nearing a $1 billion target in GLP-1-related revenue, and it has raised its dividend for 54 consecutive years.

Impact on stocks 3

Biotech & Genomic Medicine▲ · 2 stocks
AbbVie Inc
ABBV
▲ PositiveCapitalrelevance

Motley Fool analysis recommends buying AbbVie on the dip, citing strong Q1 results and growth drivers Skyrizi and Rinvoq.

Becton Dickinson and Company
BDX
▲ PositiveCapitalrelevance

Motley Fool analysis recommends buying Becton Dickinson on the dip, citing recurring revenue and GLP-1-related revenue target.

Consumer Staples▲ · 1 stocks
Walmart Inc.
WMT
▲ PositiveCapitalrelevance

Motley Fool analysis recommends buying Walmart on the dip, citing its EDLP model, e-commerce growth, and dividend streak.

© 2026 MarketDXNews